Contineum Therapeutics’ $110 Million IPO

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Contineum Therapeutics in the offering, and Sidley Austin represented the underwriters.Contineum Therapeutics, a clinical stage biopharmaceutical company, announced…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now